Zealand Pharma enters AI partnership with Iktos

The French startup specialized in using artificial intelligence in drug design will help Zealand Pharma investigate new potential peptide-based drugs.

Photo: Zealand Pharma / PR

Danish pharmaceutical firm Zealand Pharma is not new to developing peptide-based drugs, but is now adding another tool to its toolbox by partnering up with Iktos, a French startup company specialized in artificial intelligence, according to a press release.

With a number of successful peptide projects behind Zealand Pharma, the collaboration with leverage the Danish firm’s expertise and Iktos’s capabilities in machine learning and AI to develop a technology for peptide drug design.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs